Harmony Biosciences Holdings, Inc.
HRMY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802665
In the last 90 days, Harmony Biosciences Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $1.97B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Harmony Biosciences Holdings, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 184
- +6 vs. Q1 2022
- Shares held
- 47.7M
- +1.58M (+3.4%) vs. Q1 2022
- Total value
- $2.34B
- +$83.1M (+3.7%) vs. Q1 2022
- New holders
- 30
- 72 more added
- Sold out
- 24
- 63 more reduced
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HRMY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 328 | $1.97B |
| Q1 2026 | 311 | $1.57B |
| Q4 2025 | 325 | $1.87B |
| Q3 2025 | 296 | $1.31B |
| Q2 2025 | 279 | $1.62B |
| Q1 2025 | 272 | $1.67B |
| Q4 2024 | 247 | $1.82B |
| Q3 2024 | 234 | $2.01B |
| Q2 2024 | 219 | $1.51B |
| Q1 2024 | 207 | $1.64B |
| Q4 2023 | 221 | $1.54B |
| Q3 2023 | 205 | $1.62B |
| Q2 2023 | 211 | $1.83B |
| Q1 2023 | 218 | $1.68B |
| Q4 2022 | 242 | $2.81B |
| Q3 2022 | 203 | $2.24B |
| Q2 2022 | 184 | $2.34B |
| Q1 2022 | 182 | $2.26B |
| Q4 2021 | 147 | $1.90B |
| Q3 2021 | 102 | $1.19B |
| Q2 2021 | 84 | $790.3M |
| Q1 2021 | 57 | $907.6M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Harmony Biosciences Holdings, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −1,533−100.0% | Sold out |
| Catalyst Capital Advisors LLC | 0 | $0 | 0.00% | −560−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −93−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Kayne Anderson Rudnick Investment Management LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Cordant, Inc. | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |
| Teachers Retirement System of the State of Kentucky | – | – | – | – | Not filed |
| SJS Investment Consulting Inc. | – | – | – | – | Not filed |